The Pharma Data

MARCH 30, 2021

2] – The atogepant application demonstrates AbbVie’s longstanding commitment to providing multiple migraine treatment options, including BOTOX® (onabotulinumtoxinA), a preventive treatment for those with chronic migraine, and UBRELVY® (ubrogepant), an acute treatment for adults with migraine. .

Treatment 52

Treatment FDA Doctors Drugs 52

FDA Law Blog: Drug Discovery

DECEMBER 7, 2022

Valentine — On November 22, 2022, FDA approved CSL Behring’s BLA for Hemgenix (etranacogene dezaparvovec), an AAV-based gene therapy for the treatment of adults with Hemophilia B who currently use Factor IX prophylaxis therapy, have current or historical life-threatening hemorrhage, or have repeated, serious spontaneous bleeding episodes.

Therapies 119

Therapies FDA FDA Approval Treatment 119

The Pharma Data

SEPTEMBER 29, 2020

Prof John Wright, a doctor and epidemiologist, is head of the Bradford Institute for Health Research, and a veteran of cholera, HIV and Ebola epidemics in sub-Saharan Africa. Earlier this month, though, someone who’d attended the temple tested positive for Covid-19 and all those present on the same day had to self-isolate for two weeks.

Doctors 52

Doctors Trials Virus Government 52

The Pharma Data

JULY 21, 2021

– Allergan, an AbbVie (NYSE: ABBV) company, today announced that it will present new data from its leading portfolio of eye care medicines at the 2021 ASCRS (American Society for Cataract and Refractive Surgery) Annual Meeting being held July 23-27 in Las Vegas, NV. Details about Allergan’s presentations are as follows: .

Treatment 52

Treatment Doctors Production FDA Approval 52

National Drug & Alcohol Research Centre Blog

NOVEMBER 21, 2023

38 NDARC attendees (plus five virtual attendees) shared their research during two keynote presentations, 20 oral presentations, 11 poster presentations, one-panel session, one clinical trial stand, and plenty of lunchtime networking. Sara giving her keynote presentation. Rebecca giving her keynote presentation.

Clinical Trials 72

Clinical Trials Trials Doctors Research 72

Common Sense for Drug Policy Blog

FEBRUARY 20, 2024

Prescriber Attitudes, Beliefs, Stigma, and Treatment of Opioid Use Disorder "A study in Canada found that personal beliefs of NPs often pose a barrier to providing treatment, for example, views such as patients with OUD deserve less care than other patients [ 12 ], this was also reported as a barrier in the study by Spetz and colleagues [ 31 ].

Treatment 40

Treatment Nurses Pharmacy Doctors 40

The Pharma Data

JANUARY 14, 2021

COHASSET, MA, January 14, 2021 /24-7PressRelease/ — Marquis Who’s Who, the world’s premier publisher of biographical profiles, is proud to present Harvey Leonard Dickstein, MD, with the Albert Nelson Marquis Lifetime Achievement Award. More recently, he was a member of the Cohasset Board of Health between 2015 and 2018.

Laboratories 52

Laboratories Clinical Research Hospitals Pharmaceuticals 52

KIF1A

MAY 24, 2023

The approach often focuses the patient-voice around a common goal of treatment, be it to inform a clinical endpoint or identify patient demographics for a drug treatment. One approach is to target common entities in the therapeutic development process such as regulatory agencies, established clinicians, and biopharmaceutical companies.

Disease 98

Disease Laboratories Research Science 98

Conversations in Drug Development Trends

NOVEMBER 10, 2023

At this year’s annual Pain Therapeutics Summit , which took place in San Diego, CA, October 19 to 20th, I heard brilliant presentations on novel pain medication development, targeted discoveries, pain classifications, the NIH HEAL Initiative , trial designs, biomarkers, and others.

Clinical Trials 75

Clinical Trials Trials Treatment Compliance 75

biobide

FEBRUARY 2, 2024

Pediatric cancers exhibit differences at the genetic level compared to the same form of adult disease, which may influence the selected treatment. Zebrafish Pioneers Advance in Pediatric Cancer Research and Treatment Increasing the survival rate is the primary goal when screening for cancer drugs.

Disease 59

Disease Medical Schools Pharma Companies Clinical Trials 59

Drug Target Review

JANUARY 30, 2024

Considering the translational potential of this research to clinical applications, what are the key preclinical findings that present the 3A5C7 monoclonal antibody as a promising therapeutic option for managing morphine tolerance in humans? Mechanisms of rapid opioid receptor desensitization, resensitization and tolerance in brain neurons.

Treatment 52

Treatment Doctors Cell Biology Regulations 52

Eye on FDA

JUNE 14, 2023

The latest letter was issued for a website that promoted a treatment for hypercortisolemia in patients with Cushings Disease. The agency acknowledged that full risk information was presented on the webpage, but felt that did not mitigate the overall characterization that minimized risk. There are no apparent answers.

FDA 82

FDA Production Doctors Treatment 82

Drug Target Review

DECEMBER 13, 2023

This is likely indicative of the heterogeneous nature of the disorder, and it is this complexity and diversity of clinical presentation and effects across multiple organ systems, that has made efforts to identify genetic risk factors using traditional genomic analysis approaches extremely challenging.

Bioinformatics 145

Bioinformatics Disease Regulations Immune Response 145

Drug Target Review

SEPTEMBER 22, 2023

This heterogeneity, present within the same structure or between various organoids, could complicate our understanding of specific mechanisms of action when testing novel drugs in vitro. Stem cell-derived organoids and their application for medical research and patient treatment. Nat Rev Bioeng [Internet]. 2023 Jan 19;1(1):32–45.

Clinical Research 116

Clinical Research Research Drug Development Molecular Biology 116

NIH Director's Blog: Drug Development

SEPTEMBER 26, 2019

As a second and more challenging test, the researchers reconfigured the BOC by placing a multi-drug resistant vulva cancer cell line in one chamber and, in another, a breast cancer cell line that responded to drug treatment. Both tamoxifen alone and the combination treatment showed some off-target effects on heart cells.

Drugs 72

Drugs Science Treatment Clinical Trials 72

Olympian Clinical Research

DECEMBER 1, 2022

The type of psoriasis you experience can influence the symptoms and complications associated with your condition as well as the treatment plan that is right for you. To help relieve the itching and inflammation associated with plaque psoriasis, your doctor may prescribe a topical ointment or steroid. million US adults. .

Clinical Trials 52

Clinical Trials Doctors Clinical Research Treatment 52

The Pharma Data

SEPTEMBER 10, 2021

today announced that data from its robust neuroscience portfolio will be presented at the International Parkinson and Movement Disorder Society (MDS) Virtual Congress 2021, taking place September 17-22. More than 20 abstracts across disease states, including Parkinson’s disease, spasticity and cervical dystonia, will be presented.

Doctors 52

Doctors Clinical Trials Disease Treatment 52

Olympian Clinical Research

AUGUST 19, 2022

While these conditions cannot be cured, there are treatments available that may lessen the symptoms. In addition, clinical research may provide new information and breakthrough treatments. . Therefore finding treatment options that may help lessen the symptoms is important. . Treatment Options for Pediatric Psoriasis.

Clinical Research 52

Clinical Research Treatment Doctors Licensing 52

Drug Target Review

FEBRUARY 29, 2024

The rigors of training as a physician-scientist present their share of obstacles to overcome. As a growing field, gene therapy also presents its challenges and I have made personal sacrifices along the way. Nevertheless, the potential to pioneer and move the needle for patients with few treatment options drives me to push through.

Therapies 111

Therapies Disease Clinical Trials Science 111

The Pharma Data

AUGUST 19, 2020

Linda Nolan and Bill Turnbull have joined NHS doctors in encouraging cancer checks. Singer Linda Nolan and presenter Bill Turnbull are among the celebrities with cancer who are urging the public not to put off seeking important checks. Linda and Anne Nolan both having cancer treatment. Image copyright. Image caption.

Doctors 52

Doctors Treatment Disease 52

The Pharma Data

DECEMBER 9, 2020

9, 2020 — Side effects of radiation therapy in breast cancer patients are often missed by doctors, U.S. It was common for treatment side effects such as pain, itchy skin, swelling and fatigue to go unrecognized. WEDNESDAY, Dec. researchers report.

Therapies 52

Therapies Doctors Research Treatment 52

Olympian Clinical Research

SEPTEMBER 16, 2021

Plaque psoriasis presents itself as patches of red, raised skin covered with silvery scales, along with a red bulbous base. Psoriasis Treatment Options. Once psoriasis is diagnosed, treatment is determined based on the level of severity and if there is a presence of joint involvement, known as psoriatic arthritis.

Clinical Research 52

Clinical Research Therapies Clinical Trials Disease 52

Altus Drug Development

MAY 31, 2022

Value-added medicines offer the medical world the opportunity to increase the quality of treatments as well as expand access to healthcare for more people. Value-added medicines are drug products and treatments created using known molecules through a process known as drug repositioning. What is a value-added medicine?

Treatment 52

Treatment Pharmaceuticals Production Doctors 52

KIF1A

MAY 27, 2023

After speaking at our 2019 conference and receiving her doctorate, Dr. Lessard joined KIF1A.ORG as its first staff scientist, bringing with her a wealth of expertise in KIF1A, both her own and that of her research colleagues. Read more to learn about the factors involved in incentivizing investment in rare disease treatments.

Science 94

Science Disease Small Molecule Research 94

PLOS: DNA Science

OCTOBER 19, 2023

Also recently, FDA’s Cellular, Tissue, and Gene Therapies Advisory Committe turned down a stem cell treatment for amyotrophic lateral sclerosis, aka ALS, Lou Gehrig’s disease, or motor neuron disease. The only treatment for ALS is a drug, Riluzole , taken as a tablet or a film. The pace though varies quite a lot.

Therapies 105

Therapies FDA Clinical Trials Disease 105

The Pharma Data

NOVEMBER 11, 2020

McChesney is the founder and chief executive officer of Cloaked Therapeutics and Arbor Therapeutics, through which he has drawn on more than five decades of research in natural products chemistry to identify and develop novel cancer treatments.

Science 52

Science Organic Chemistry Pharmaceuticals Pharmacy 52

The Pharma Data

OCTOBER 30, 2020

Since the outbreak of the novel coronavirus spread across the globe, doctors and public health officials have warned of particular symptoms associated with the virus, including a dry cough, fever and shortness of breath, among others, such as headache, chills or a sore throat. The sound of coughing and gasping breath is coming up fast.

Doctors 52

Doctors Virus Disease Treatment 52

Drug Target Review

FEBRUARY 26, 2024

Rather than solely identifying tumour-associated mutations which can be specifically targeted for effective treatment, we now need to consider how non-mutational events play into both the development of the primary tumour and the development of therapy resistance.

Therapies 59

Therapies Molecular Biology Medical Schools Regulations 59

Broad Institute

JANUARY 31, 2022

/infectious-disease-microbiome Kidney disease Our scientists are cataloging the molecular causes of kidney diseases in order to develop mechanism-based treatments. obesity Psychiatric disorders We are committed to characterizing psychiatric disorders' molecular roots and turning new findings into new treatments.

Science 52

Science Regulations Disease Treatment 52

The Pharma Data

NOVEMBER 19, 2020

The procedure is a form of radiofrequency ablation, where doctors use needles to send a low-grade electrical current to nerves that are transmitting pain signals from the arthritic joint to the brain. None of the study patients received a placebo (inactive treatment) to serve as a comparison, said Bhatt, of Prime Rheumatology in Katy, Texas.

Treatment 52

Treatment Therapies Doctors Disease 52

Drug Target Review

SEPTEMBER 18, 2024

How is AI being integrated into current cell and gene therapy manufacturing processes to enhance operational efficiency and accelerate treatment access? At the recent ISCT 2024 – Signature Series, researchers from Charles River Laboratories presented a study 1 to predict the optimal cell culture parameters using a ML model.

Therapies 52

Therapies Doctors RNA Production 52

The Pharma Data

DECEMBER 8, 2020

. “I think anyone who’s been a fan of rap music across the last two decades — myself included — had a feeling this was happening,” said study author Alex Kresovich, a doctoral fellow in the Hussman School of Journalism and Media at the University of North Carolina at Chapel Hill. ” Kresovich agreed.

Doctors 52

Doctors Treatment Research 52

The Pharma Data

APRIL 6, 2022

Additional details of this trial will be presented at future medical congresses and will serve as the basis for a supplemental New Drug Application submission for an optional twice-daily administration to the U.S. Presbyopia can be diagnosed by an eye doctor (ophthalmologist/optometrist). ” About Presbyopia. About VUITY.

Trials 52

Trials FDA FDA Approval Clinical Trials 52

The Pharma Data

JANUARY 20, 2021

Food and Drug Administration (FDA) has accepted the company’s supplemental New Drug Application (sNDA) and granted Priority Review for Esbriet ® (pirfenidone) for the treatment of unclassifiable interstitial lung disease (UILD). However, each ILD has different causes, treatment approaches, and outlooks. Since its U.S. mL, p=0.002).

FDA 40

FDA Disease Doctors Treatment 40

KIF1A

JUNE 30, 2023

As families, scientists, doctors and our friends around the world navigated the challenges of 2022, the KIF1A.ORG community worked together to reach new heights. KAND Clinician Directory : Trying to find a doctor? This short, 4-minute video helps families, doctors, teachers, friends and others understand KAND in plain language.

Small Molecule 52

Small Molecule Treatment Doctors Research 52

Drug Target Review

JUNE 3, 2024

By encapsulating specific self-antigens within our biodegradable nanoparticles, we enable the targeted delivery of the CNPs to antigen-presenting cells (APCs) primarily in the spleen and liver. This process results in anergy, deletion, production of regulatory T cells and downregulation of the antigen-specific T cell response.

Disease 49

Disease Therapies Pharmaceuticals Treatment 49

Perficient: Drug Development

NOVEMBER 2, 2023

Whether they’re afraid of a bad diagnosis, afraid of a difficult treatment or simply afraid of the doctor in general, virtually no other service category has to overcome a basic fear of the service with the consumer. But for people with fear of the doctor or fear of the healthcare process, that’s exactly what you have to do.

Doctors 52

Doctors Treatment Research Marketing 52